ライフサイエンスコーパス: Pluronic

1 chimeras and transcription activation by the pluronic.

2 ntration of the adhesion-reducing surfactant pluronic.

3 Pluronic 10%, plasma, and serum were used as emulsifiers

4 or of gold nanospheres (AuNS) in presence of pluronic acid (PA) modified single-walled carbon nanotub

5 olymers based on PEO and PPO (Poloxamers and Pluronics) and advances in the area of PEGylation as the

6 Pluronic-based oil-in-water microemulsions were synthesi

7 HPbetaCD, improved cholesterol egress, while Pluronic block copolymers capable of micelle formation s

8 peutic efficacy of Doxil(R) by administering Pluronic block copolymers once the liposomal drug accumu

9 Variation of aqueous Pluronic concentrations allows for a systematic variatio

10 nsist of a dendritic polyethylene core and a Pluronic copolymer shell.

11 ipid-PEG conjugates were more effective than Pluronic copolymers in generating stable, surface neutra

12 cy with delayed administration indicate that Pluronic copolymers may provide a novel, membrane-target

13 e glycol) (PEO-PPO-PEO) triblock copolymers (Pluronic)] could only disperse MWNTs via ultrasonication

14 Encapsulation of the new probes in Pluronic F 108NF micelles, and subsequent incubation in

15 ve MD catheter and one surface modified with Pluronic F-127 (10 mm membrane, 100 kDa molecular weight

16 Pluronic F-68 (F-68) or pluronic F-127 (F-127) was administered either topically

17 n nanospheres composed of triblock copolymer Pluronic F-127 and bis(2-ethylhexyl) sebacate.

18 iminary studies, we detected that the use of pluronic F-127 appeared to be affecting the depolarizati

19 (SCN), quickly migrated to soybean roots in Pluronic F-127 gel.

20 These results indicate that pluronic F-127 significantly alters depolarization-evoke

21 ns, NC crystallized in the medium containing Pluronic F-127 then coated with albumin ("Cim-F-alb") ha

22 ividual and combined effects of glycerol and Pluronic F-127 were of lesser magnitude than those obtai

23 Small proportions of glycerol, Pluronic F-127, and glucosylceramide enhanced naproxen e

24 In the absence of pluronic F-127, the KCl-evoked [Ca2+]cyt transient chang

25 ng encapsulated with biodegradable copolymer pluronic F-127-folic acid (F-127-FA), RET-BDP molecules

26 Fura-2 AM is often facilitated by the use of pluronic F-127.

27 in neurons Fura-2 loaded in the presence of pluronic F-127.

28 M in the absence or in the presence of 0.02% pluronic F-127.

29 Pluronic F-68 (F-68) or pluronic F-127 (F-127) was admin

30 serum controls by very low concentrations of Pluronic F-68 and F-127 by 30 minutes, with attachment r

31 Here, we demonstrate the efficacy of Pluronic F-68 in rescuing rat hippocampal neurons from a

32 ing human dentin sections as a substrate and Pluronic F-68 or F-127 at a concentration of 1.2 x 10(-8

33 l media (EMEM) with 10% fetal calf serum and Pluronic F-68 or F-127 in concentrations from 1.2 x 10(-

34 Gelatin Peptone N3, N-Acetyl-L-Cysteine and Pluronic F-68) were assayed in order to improve producti

35 Pluronic F-68, a detergent believed to aid in healing of

36 Pluronic F-68, an 80% hydrophilic member of the Pluronic

37 To solve this problem, a surfactant (Pluronic F108) was chemically modified with the metal-ch

38 The hydrogels examined were pluronic F127 (PF127), Matrigel and PuraMatrix.

39 Concentrated (18-30%) solutions of Pluronic F127 are freely flowing liquids at low temperat

40 ical nucleic acid (SNA) nanostructures using Pluronic F127 as a thermoresponsive template is reported

41 sidual PVA prevented sufficient coating with Pluronic F127 capable of reducing particle mucoadhesion.

42 of amphiphilic (porphyrin)Sn 1 in an aqueous Pluronic F127 media results in the formation of narrowly

43 stimulation) into the hydrophobic regions of Pluronic F127 micelles, followed by chemical cross-linki

44 laponite along with a surfactant stabilizer (Pluronic F127) and the photoacid generator (PAG), diphen

45 Pluronic F127, representative of the copolymer class, co

46 n in the common biocompatible coating agents Pluronic F127, ss-DNA, and BSA is approximately an order

47 al solution temperature (LCST) properties of Pluronic F127, the particles exhibit temperature respons

48 Pluronic F127-based microemulsions extracted bupivacaine

49 emperature responsive properties utilizing a Pluronic F127/dextran aqueous two-phase system (ATPS) as

50 The PLGA polymer, when emulsified in Pluronic F127/dextran ATPS, forms unique microparticle s

51 as the non-coated polyester analogue and the Pluronic F68 alone had no effect.

52 s (FITC, Alexa647 and BODIPy-TR), mixed with pluronic F68 and linear polyethyleneimine (PEI), and emu

53 s tested, in all assays, it was found that a Pluronic F68 coated poly (decanediol-phenylsuccinate-co-

54 ons of this polymer either with or without a Pluronic F68 stabilizing coating was assessed in vitro u

55 e serum albumin, Tween-80, Triton X-100, and Pluronic-F68.

56 ronic F-68, an 80% hydrophilic member of the Pluronic family of polyethylene-polypropylene-polyethyle

57 ventitial delivery of resveratrol either via Pluronic gel (2-week), or polymer sheath (3-month), effe

58 tides into mouse skin wounds by release from Pluronic gel decreases OPN protein levels at the wound a

59 acted as a growth inhibitor in vivo, we used pluronic gel delivery of RpL17 small interfering RNA to

60 iver OPN antisense oligodeoxynucleotides via Pluronic gel to the surface of injured, juxtaposed small

61 ginine methyl ester (L-NAME) in 22% (wt/vol) Pluronic gel, while the contralateral vessel was coated

62 grafts were treated locally with aspirin in pluronic gel-127, the thrombus area was significantly re

63 Feeding Pluronic L-81 (BASF Wyandotte, Wyandotte, MI), a deterge

64 effects of MCTs could be mimicked by adding Pluronic L81 to LCTs, and in vitro assays indicated that

65 plus an inhibitor of chylomicron formation (Pluronic L81).

66 on of large CM was specifically inhibited by Pluronic L81, a detergent known to inhibit CM secretion

67 Dox was encapsulated within stabilized Pluronic micelles and administered weekly i.v. to the ra

68 Encapsulation of Dox using stabilized Pluronic micelles and localized release using low-freque

69 tain a series of in-depth profiles from PLLA/Pluronic-P104 (poly(ethylene oxide-co-propylene oxide) t

70 d copolymer systems, with a surface enriched Pluronic-P104 region, followed by a P104 depletion layer

71 precursor and the block-copolymer templates Pluronic P123 and F127 does not occur during evaporation

72 es in the presence of the triblock copolymer Pluronic P123.

73 modified the N-terminal amine of leptin with Pluronic P85 (LepNP85) and administered this conjugate i

74 oly(propylene oxide)-b-poly(ethylene oxide), Pluronic P85 (P85) might permit this protein to penetrat

75 The effects of Pluronic P85 and mild hyperthermia in vitro were tested

76 or localized release of Dox from liposome by Pluronic P85 at the tumor site, which was therapeuticall

77 epNPEG5K), and two conjugates of leptin with Pluronic P85 attached randomly to the lysine amino group

78 control tumors (P = .03) after intratumoral Pluronic P85 but was unchanged after systemic Pluronic P

79 images were carried out to determine whether Pluronic P85 could facilitate release of Dox from Doxil(

80 moral (13 tumors) or intravenous (15 tumors) Pluronic P85 followed by ablation or with ablation alone

81 Tumor pretreatment with Pluronic P85 improved the outcome of RF ablation by decr

82 Acute effects of Pluronic P85 on the size of ablation-induced coagulation

83 e of tumors ablated after local and systemic Pluronic P85 pretreatment changed by -55% +/- 14 (P = .0

84 At 43 degrees C, 7% and 10% Pluronic P85 reduced in vitro cell viability by 22% +/-

85 Addition of Pluronic P85 resulted in release of Dox from the liposom

86 ngle injection of Doxil(R) was achieved when Pluronic P85 was administered 48h after Doxil(R).

87 and distribution of drug were evaluated when Pluronic P85 was injected 1h, 48h, or 96h after the Doxi

88 for 15-60 minutes with 0%, 7%, or 10% wt/wt Pluronic P85, and cell viability was assessed by using a

89 nvestigate the drug release from liposome by Pluronic P85.

90 luronic P85 but was unchanged after systemic Pluronic P85.

91 Liposome modification with PEG copolymers (Pluronics), phospholipid-PEG conjugates and chitosan wer

92 tric assay for quantitative determination of Pluronic (poloxamer) and Tetronic (poloxamine) macromole

93 Here, we show that Pluronic (Poloxamer) block copolymers are amenable to lo

94 Pluronics polymer material is PCR compatible, and 30% Pl

95 Pluronics polymer phase change valves were implemented i

96 polymer material is PCR compatible, and 30% Pluronics polymer valves provide enough holding pressure

97 ersatility, availability, and ease of use of Pluronic polymers offer major advantages over convention

98 differences, the overall trend was that the pluronic polyol and the mode of administration did not r

99 Pluronic polyols are a family of non-ionic surfactants c

100 Pluronic polyols are easily mixed with either DBP or TCP

101 tudy was to determine the in vivo effects of pluronic polyols combined with either an allograft or an

102 Pluronic polyols may be considered as carriers for osseo

103 udy was to determine the in vitro effects of pluronic polyols, a family of widely used surfactants cu

104 Pluronic polyols, a family of widely used surfactants, i

105 Our data demonstrate that the presence of Pluronic(R) F-127 (0.05-0.30%) also helps enhance resolu

106 In this research, a novel material, Pluronic(R) F-127, which has the properties of polymer a

107 esize that the combination of RES and QUE in Pluronic(R) F127 micelles (mRQ) when co-administered wit

108 earing mice showed that PTX-NCs treated with Pluronic(R) F68 (PEG-PPG-PEG block polymer) significantl

109 xyl) sebacate (DOS) and a triblock copolymer Pluronic((R)) F-127, which also functions as a surfactan

110 to quantify the in-depth surface segregated Pluronic region.

111 Thermoresponsive smart electrolytes based on Pluronic solution are developed for active control and t

112 attributed to the sol-gel transition of the Pluronic solution upon temperature change.

113 Coinjection with pluronic SP1017 produced further enhancement of gene exp

114 than microemulsions synthesized using other Pluronic surfactants (L44, L62, L64, F77, F87, F88, P104

115 A Tris-Acetate-Phosphate-Pluronic (TAPP) medium that undergoes a thermoreversible

116 ature locally, to approximately 5 degrees C, Pluronics valves were liquefied and easily opened.

117 d using the biocompatible triblock copolymer Pluronic, which allowed the comparison in the transport